SEATTLE, Jan. 7, 2014 /PRNewswire/ — Seattle-based Nordstrom, Inc., (NYSE: JWN) announced today plans to open a Nordstrom Rack at The Shops at SkyView Center in Queens, N.Y. The approximately 39,000-square-foot, two-level store is scheduled to open in fall 2014. The developer for the project is Onex Real Estate Partners. Nordstrom Rack is the off-price […]
SEATTLE, Jan. 7, 2014 /PRNewswire/ — Seattle-based Nordstrom, Inc. (NYSE: JWN) announced today plans to open a Nordstrom Rack at Lake Brandon Plaza in Brandon, Fla. The approximately 32,700-square-foot store is scheduled to open in fall 2014. Lake Brandon Plaza is owned and managed by DDR Corp. (NYSE: DDR). Nordstrom Rack is the off-price retail […]
NEW YORK, Jan. 2, 2014 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, today announced that it will provide an update on the progress of its clinical development programs after theNASDAQ Market closes on January 9, 2014. This update will […]
– Collaboration represents the first time the ACC’s PINNACLE Registry Research Alliance will be used for clinical trial recruitment – Paris, France and Tarrytown, New York – December 19, 2013 – Sanofi (EURONEXT : SAN and NYSE : SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ : REGN) announced today an innovative collaboration with the American College […]
NEW YORK– December 19, 2013 — (BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) announced today that FETZIMA™ (levomilnacipran ER capsules), is now available in pharmacies throughout the United States. FETZIMA was approved by the U.S. Food and Drug Administration (FDA) for the treatment of Major Depressive Disorder (MDD), also known as depression, in adults in July 2013. […]
TARRYTOWN, N.Y., Dec. 18, 2013 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company’s supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review of an sBLA […]
Dec 17, 2013 – Ultra-luxury Silversea Cruises has appointed Angela Composto as its new vice president of marketing for the Americas, reporting to Kristian Anderson, senior vice president of sales and general manager for North America. She will be based in the Fort Lauderdale office. With 20 years of experience in marketing management and promotion, […]
MALVERN, Pa., Dec. 16, 2013 /PRNewswire/ — Accretive transaction furthers Endo’s transformation into leading specialty healthcare company Builds on Endo’s leadership in pain management through addition of ZECUITY® (sumatriptan iontophoretic transdermal system), the first and only FDA approved patch to treat migraine Proven Endo branded pharmaceuticals commercial team to execute ZECUITY launch, expected in first half 2014 Endo […]
NEW YORK– December 9, 2013 — (BUSINESS WIRE) –Forest Laboratories, Inc. (NYSE:FRX) today announced appointments to its executive leadership team. The appointments are part of Forest’s announced plans to flatten and broaden the organization as part of Project Rejuvenate. “Today we are announcing an important step to rejuvenate our company by creating the first Forest Executive Team […]
– Sovaldi Approved for Use in Genotypes 1, 2, 3 or 4 – – High Cure Rates (SVR12) and Shortened, 12-Week Course of Therapy for Many Patients – – First Ever Oral Treatment Regimen for Genotypes 2 or 3 – – First Regimen for Patients Awaiting Liver Transplantation to Prevent HCV Recurrence – FOSTER CITY, […]